ACL Digital has taken a significant step forward in the clinical research industry. The company has acquired Symbiance, a US-based contract research organization (CRO), to enhance its digital and AI-driven capabilities in life sciences. This move signals a bold expansion to meet the evolving demands of global pharmaceutical, biotech, and medical device clients.
ACL Digital Strengthens Clinical Research Through Acquisition
With the acquisition of Symbiance, ACL Digital positions itself as a leading end-to-end provider of clinical research and data CRO solutions. This strategic move empowers ACL Digital to offer a broader scope of services, including:
- Clinical data management
- Data standardization
- Biostatistics and statistical programming
- Medical writing
- Pharmacovigilance
The integration enhances ACL Digital’s global presence and delivers more value to its partners across the life sciences sector.
Combining AI-Driven Solutions With Deep Clinical Expertise
By joining forces, ACL Digital and Symbiance aim to accelerate digital transformation in clinical research. ACL Digital’s AI-powered offerings will combine with Symbiance’s established track record in clinical research services. Together, they will deliver:
- Intelligent, data-driven solutions
- Operational excellence
- Patient-centric and transformative services
Executives from both organizations express strong confidence in exceeding industry standards and empowering clients with cutting-edge technologies.
Future Growth and Innovation in Life Sciences and CRO Services
This partnership underlines ACL Digital’s commitment to innovation and client success in the life sciences and CRO space. Symbiance brings a unique blend of “people + product” delivery models, enhancing ACL Digital’s ability to serve current and future customers. The combined teams will leverage proprietary tools and analytics, ensuring quality and reliability in every project. This collaboration places ACL Digital in a strong position to drive future-ready clinical research solutions.
In summary, ACL Digital’s acquisition of Symbiance represents a major leap in clinical research and digital transformation. By integrating advanced AI with trusted clinical expertise, ACL Digital is prepared to lead the industry, support global innovation, and deliver improved outcomes for its clients.
Don’t miss our latest Startup News: Belden Industrial Ethernet Cables Deliver Superior Reliability for Industry
